Type 2 Diabetes
No difference in CV autonomic neuropathy with dapagliflozin vs. glimepiride
Adults with type 2 diabetes experienced no difference in cardiovascular autonomic neuropathy measures or B-type natriuretic peptide levels after 12 weeks of dapagliflozin therapy vs. 12 weeks of glimepiride, according to trial data.
Dulaglutide switch from insulin lowers HbA1c, body weight in type 2 diabetes
Adults with type 2 diabetes in South Korea had lower HbA1c and body weight 6 months after switching from insulin to the GLP-1 receptor agonist dulaglutide, according to a study published in Diabetes/Metabolism Research and Reviews.
Higher fiber, milk intake may impact host metabolic health in type 2 diabetes
Higher fiber and milk intake correlated with favorable circulation of tryptophan metabolites for type 2 diabetes, according to a study published in Gut.
Top in cardiology: Type 2 diabetes risk score, decline in Kawasaki disease
Researchers developed a genetic risk score that depicts the relationship between variants in HMGCR and pleiotropic effects of statins. They found that a certain HMGCR risk score was associated with an increased odds of type 2 diabetes.
MOBILE: CGM benefits adults with type 2 diabetes using basal insulin in primary care
Adults with type 2 diabetes prescribed basal insulin without prandial insulin therapy saw significant improvements in HbA1c 8 months after initiating real-time continuous glucose monitoring, according to an analysis of primary care data.
Low-calorie diet may effectively ‘replace’ BP medications in type 2 diabetes
Replacing antihypertensive medications with a low-calorie diet to induce weight loss substantially reduces blood pressure and may increase mild dizziness for adults with type 2 diabetes, according to a post hoc analysis of the DiRECT study.
Daily fruit consumption may lower type 2 diabetes risk
Adults who eat two servings of fruit per day are 36% less likely to develop type 2 diabetes during 5 years of follow-up compared with those who eat less than half a serving of fruit daily, data from an observational study show.
Long-term testosterone therapy may improve NAFLD symptoms in men
Two-year therapy with testosterone undecanoate normalized serum testosterone levels and reduced nonalcoholic fatty liver disease grade among men with obesity, functional hypogonadism and type 2 diabetes, data show.
Top in endocrinology: SGLT2 inhibitors, tirzepatide for type 2 diabetes
Two experts debated whether SGLT2 inhibitors should be used as a first-line therapy for patients with type 2 diabetes. This point-counter point was the top story in endocrinology last week.